- Home
- TCRT vs BDRX Comparison
TCRT vs BDRX Comparison
Compare TCRT & BDRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TCRT
- BDRX
- Stock Information
- Founded
- TCRT 1998
- BDRX 2000
- Country
- TCRT United States
- BDRX United Kingdom
- Employees
- TCRT N/A
- BDRX N/A
- Industry
- TCRT Biotechnology: Pharmaceutical Preparations
- BDRX Biotechnology: Pharmaceutical Preparations
- Sector
- TCRT Health Care
- BDRX Health Care
- Exchange
- TCRT Nasdaq
- BDRX Nasdaq
- Market Cap
- TCRT 2.6M
- BDRX 2.4M
- IPO Year
- TCRT N/A
- BDRX N/A
- Fundamental
- Price
- TCRT $1.68
- BDRX $3.71
- Analyst Decision
- TCRT
- BDRX
- Analyst Count
- TCRT 0
- BDRX 0
- Target Price
- TCRT N/A
- BDRX N/A
- AVG Volume (30 Days)
- TCRT 12.3K
- BDRX 1.2M
- Earning Date
- TCRT 03-31-2025
- BDRX 04-21-2025
- Dividend Yield
- TCRT N/A
- BDRX N/A
- EPS Growth
- TCRT N/A
- BDRX N/A
- EPS
- TCRT N/A
- BDRX N/A
- Revenue
- TCRT $7,000.00
- BDRX $104,895.00
- Revenue This Year
- TCRT N/A
- BDRX N/A
- Revenue Next Year
- TCRT N/A
- BDRX N/A
- P/E Ratio
- TCRT N/A
- BDRX N/A
- Revenue Growth
- TCRT N/A
- BDRX N/A
- 52 Week Low
- TCRT $1.50
- BDRX $3.36
- 52 Week High
- TCRT $26.00
- BDRX $74.00
- Technical
- Relative Strength Index (RSI)
- TCRT 48.71
- BDRX 38.74
- Support Level
- TCRT $1.59
- BDRX $3.36
- Resistance Level
- TCRT $1.70
- BDRX $5.30
- Average True Range (ATR)
- TCRT 0.09
- BDRX 0.74
- MACD
- TCRT 0.01
- BDRX -0.08
- Stochastic Oscillator
- TCRT 69.23
- BDRX 5.99
About TCRT Alaunos Therapeutics Inc.
Alaunos Therapeutics Inc is a clinical-stage cellular immuno-oncology company dedicated to the treatment of solid tumors through adoptive TCR-T cell therapy. It strikes cancer at its core by engineering cell therapies that target Neoantigens arising from genomic mutations.
About BDRX Biodexa Pharmaceuticals plc American Depositary Shs
Biodexa Pharmaceuticals PLC is a drug delivery technology company focused on improving the bio-delivery and bio-distribution of medicines. The company combines approved and developed medications with its proprietary and drug delivery technologies to provide compelling products that have the potential to powerfully impact the lives of patients.